Catalyst Wire Dossier Catalyst Wire Dossier

MIMS System

· Sanoculis Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MIMS System, covering 2025-07-04 to 2025-07-04. Get the full timeline:

Most recent: Clinical Trial Update: The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP): The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP) [NA]

See pricing